The story of LifeSense Group began in 2011 when Valer Pop, Julia Veldhuijzen van Zanten and Mitsugu Yoneyama experienced through a family member, the impact involuntary urine loss can have on daily life. These events inspired a shared mission to revolutionize healthcare with wearable technology for families worldwide. Here an overview of how together with our partners, collaborators and team we have brought this ambition to life.

2011-2015
During the early years, LifeSense Group focused on R&D, validating our first product Carin with clinical pilot trials and filing intellectual property on our innovations. Carin has been developed involving more than 100 women on its advisory board.

2016-2020
As a Start-Up from 2016 onwards we focused on validating and developing products for the market and global business exploration. During this time our products where:

Fully certified by CE, TGA, FDA, HSA, PMDA and MFDS.
Clinically proven in Italy, Singapore, Japan and Australia
Reimbursed by health insurers in The Netherlands, Australia, Taiwan and Sweden.
Recognized by an accolade of innovation awards.
Further developed and improved according to market feedback.
Signed contracts with international strategic partners.

2021 – 2026
Scaling-up LifeSense Group strives to become the global leader of digital health continence solutions. After learning from the market during our business exploration phase, our focus territories for 2021-2022 are Benelux, Germany, Taiwan, Japan and Australia.

LifeSense Group B.V. Downloads

LifeSense Group - Product Catalogue